Form 4 for DGX Quest Diagnostics
Accepted 2023-10-26 00:00:00 ET · period of report 2023-10-23 · accession 0001022079-23-000165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-26 | 2023-10-23 | DGX | Gregg Vicky B | Dir | A - Grant | $122.86 | +92 | 18.7K | +0.5% | +$11.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-23 | A | A | 92 | $122.86 | 18,741 | D | — | — | (F1) Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the Reporting Person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The Reporting Person has chosen to report such transaction early on this Form 4. |